Related references
Note: Only part of the references are listed.p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
Paolo Giorgi Rossi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase
Mahboobeh Safaeian et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA
Mark H. Stoler et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Evaluation of p16/Ki-67 Dual-Stained Cytology in Triaging HPV-Positive Women during Cervical Cancer Screening
Yuan Hu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation
Li C. Cheung et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
Nicolas Wentzensen et al.
JAMA INTERNAL MEDICINE (2019)
Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women
Megan A. Clarke et al.
JAMA ONCOLOGY (2019)
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
Mark H. Stoler et al.
GYNECOLOGIC ONCOLOGY (2018)
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs
Kate Cuschieri et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Interobserver Reproducibility of Cytologic p16INK4a/Ki-67 Dual Immunostaining in Human Papillomavirus-Positive Women
Maria Benevolo et al.
CANCER CYTOPATHOLOGY (2017)
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2017)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results
Christine Bergeron et al.
CANCER CYTOPATHOLOGY (2015)
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Warner K. Huh et al.
GYNECOLOGIC ONCOLOGY (2015)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Interpretation of p16INK4a/Ki-67 Dual Immunostaining for the Triage of Human Papillomavirus-Positive Women by Experts and Nonexperts in Cervical Cytology
Elena Allia et al.
CANCER CYTOPATHOLOGY (2015)
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
Hans Ikenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The ATHENA human papillomavirus study: design, methods, and baseline results
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations From the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Teresa M. Darragh et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2012)
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
K. Ulrich Petry et al.
GYNECOLOGIC ONCOLOGY (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
Share Paper
